|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
2024
|
P/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
P/S
|
Providing medical information in the field of hemophilia and the treatment of hemophilia. |
|
|
P/S
|
providing medical information in the field of ulcerative colitis and inflammatory bowel disease, ... |
|
|
Invention
|
Pyrido[4,3-d]pyrimidine compounds.
The invention relates to compounds of Formula (I)-(III) and p... |
|
|
Invention
|
Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-... |
|
|
Invention
|
Systems and methods for performing biological assays.
Systems and methods for performing biologi... |
|
|
Invention
|
Vepdegestrant dosage regimen in cyp3a-inducer treatment in cancer. The invention relates to a met... |
|
|
Invention
|
Deuterated antiviral compounds.
The invention relates to compounds of Formula (I)
The inventio... |
|
|
Invention
|
Deuterated antiviral compounds. The invention relates to compounds of Formula (I) (I) wherein Y1a... |
|
|
Invention
|
Methods, therapies and uses for treating cancer. The present disclosure describes therapies and u... |
|
|
Invention
|
Injection device with an improved mechanism for generating an audible feedback. The invention rel... |
|
|
Invention
|
Klf2 inducing compounds and uses thereof. The present disclosure provides compounds that are indu... |
|
|
Invention
|
Metabolites of glp1r agonists.
The present invention provides compounds of Formula XA-1, XA-2, X... |
|
|
Invention
|
Coronavirus antigen variants. The present disclosure provides isolated immunogenic polypeptides c... |
|
|
Invention
|
Lipid nanoparticles comprising polymer-conjugated lipids and uses thereof. Compounds are provided... |
|
|
Invention
|
Amphiphilic tlr7/8 adjuvants and uses thereof. The invention relates to compounds of Formula (I) ... |
|
|
Invention
|
High drug loading formulations of encorafenib. This invention relates to high drug loading formul... |
|
|
Invention
|
Solid forms of (r)-n-(3-(7-methyl-1h-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1... |
|
|
Invention
|
Combinations of estrogen receptor degraders and cdk7 inhibitors for the treatment of cancer. Disc... |
|
|
Invention
|
Treatment of multiple myeloma. Provided herein are methods of treatment of cancers, specifically ... |
|
|
Invention
|
Method for stabilizing rna. The invention relates to RNA molecules encoding an E. coli fimbrial H... |
|
|
Invention
|
Process and intermediates for preparing ibuzatrelvir. The present disclosure is directed to proce... |
|
|
Invention
|
Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv. The invention r... |
|
|
Invention
|
S)-2-oxopyrrolidin-3-yl]ethyl}-4-(trifluoromethyl)-l-prolinamide and solvates thereof. The presen... |
|
|
Invention
|
Methods and modified dosing regimens comprising a cdk4 inhibitor for the treatment of cancer. The... |
|
|
Invention
|
Combinations of estrogen receptor degraders and cdk4 inhibitors. Disclosed herein are methods for... |
|
|
Invention
|
Anti-tl1a antibody therapeutic methods. The present disclosure provides methods and compositions ... |
|
|
Invention
|
Engineered rna polymerase variants. The present disclosure relates to engineered RNA polymerase p... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof. The... |
|
|
Invention
|
Varenicline formulations. In an embodiment, there is provided a varenicline formulation consistin... |
|
|
Invention
|
Antibodies specific for cd70 and their uses.
The present invention provides antibodies that spec... |
|
|
Invention
|
Lilrb1 and lilrb2 antibodies and methods of use thereof.
The invention is directed to Anti-LILRB... |
|
|
Invention
|
Improved cells and cell cultures. Cells having improved growth and related cell cultures are prov... |
|
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof.
Described he... |
|
|
Invention
|
Calicheamicin derivatives and antibody drug conjugates thereof.
The present invention is directe... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the ... |
|
|
Invention
|
Modulators of sting (stimulator of interferon genes).
Provided herein are compounds of the gener... |
|
2023
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof.
Th... |
|
|
Invention
|
Display screen or portion thereof with graphical user interface |
|
|
Invention
|
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors.
The pres... |
|
2022
|
Invention
|
Wearable companion for detecting the cytokine release syndrome.
Embodiments disclosed herein may... |
|
|
Invention
|
Blister packaging for pharmaceuticals.
A blister package is disclosed herein. The blister packag... |
|
|
Invention
|
Digital medicine companion for treating and managing skin diseases.
A digital medicine companion... |
|
|
Invention
|
Combination therapies and uses for treating cancer.
The present disclosure relates to the treatm... |
|
|
Invention
|
Methods and dosing regimens comprising a cdk2 inhibitor and a cdk4 inhibitor for treating cancer.... |
|
|
Invention
|
Cdk4 inhibitor for the treatment of cancer.
The disclosure provides a method of treating cancer ... |
|
|
Invention
|
Crystalline form of azalactam compound.
This disclosure relates to a crystalline form of 4-[(1R)... |
|
|
Invention
|
Amorphous form of (s)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tetrahydrofuran-3-yl)pyrim... |
|
|
Invention
|
Cd21 antibodies and uses thereof.
Provided herein are anti-CD21 antibodies or antigen binding fr... |
|
|
Invention
|
Diagnostic device with led display |
|
2021
|
Invention
|
Pharmaceutical product container |
|
2020
|
Invention
|
Treatment of hidradenitis with jak inhibitors.
There are methods for treating hidradenitis suppu... |
